ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,236Medicare Part D Prescriptions Filled, Including Refills

Rank: 77 out of 2604

$460K Total Retail Price of All Prescriptions

Rank: 268 out of 2604

311 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 311 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 311 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 6,278 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 539 270 1 2
FUROSEMIDE 402 297 2 8
LISINOPRIL 364 243 3 3
OMEPRAZOLE 341 195 4 5
AMLODIPINE BESYLATE 319 206 5 6
HYDROCODONE-ACETAMINOPHEN 307 169 S3 6 1
LEVOTHYROXINE SODIUM 299 157 7 4
CARVEDILOL 275 182 8 26
GABAPENTIN 217 106 9 12
RANITIDINE HCL 208 110 10 25
POLYETHYLENE GLYCOL 3350 204 97 11 42
ALENDRONATE SODIUM 198 123 12 29
POTASSIUM CHLORIDE 191 134 13 16
SPIRIVA 172 53 14 45
TRAMADOL HCL 168 63 15 15
WARFARIN SODIUM 164 93 16 13
TAMSULOSIN HCL 148 64 17 30
FENOFIBRATE 133 22 18 69
METFORMIN HCL 132 63 19 7
GLIMEPIRIDE 132 77 19 57
ENALAPRIL MALEATE 122 51 21 50
METOPROLOL TARTRATE 121 55 22 9
OXYBUTYNIN CHLORIDE 120 94 23 92
ALLOPURINOL 112 73 24 35
LACTULOSE 106 65 25 108
ESCITALOPRAM OXALATE 101 64 26 73
ZOLPIDEM TARTRATE 95 43 27 21
CARBIDOPA-LEVODOPA 95 72 27 97
NEXIUM 94 45 29 53
HYDROCHLOROTHIAZIDE 91 28 30 10
PROAIR HFA 89 28 31 27
DIGOXIN 84 63 32 71
LEVETIRACETAM 83 32 33 96
METFORMIN HCL ER 82 81 34 72
FAMOTIDINE 82 68 34 68
CIPROFLOXACIN HCL 81 54 36 59
ATENOLOL 73 49 37 11
SERTRALINE HCL 73 43 37 23
LANTUS 71 46 39 40
PANTOPRAZOLE SODIUM 68 37 40 64
INDAPAMIDE 68 40 40 255
ALBUTEROL SULFATE 66 46 42 93
RISPERIDONE 65 50 43 65
LYRICA 61 28 44 79
ADVAIR DISKUS 60 38 45 41
CITALOPRAM HBR 60 48 45 18
NYSTATIN 60 41 45 100
BACLOFEN 55 0 48 101
COMBIVENT 51 20 49 169
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.